Lotus Lake Ventures

Lotus Lake Ventures is a venture capital investment firm based in Beijing, China, associated with Tsinghua University. The firm specializes in investing in early-stage and growth-stage companies within the science and technology sectors. Its focus areas include technology, media, telecommunications, new materials, life sciences, and clean technology, targeting enterprises that demonstrate core competitiveness and innovation.

Tao Jiang

Investment Director

Ke Yu

Investment Director

Fuqiang Zhao

Investment Director

Zhu Ph.D., Jiman

Principal

39 past transactions

Hongyun Biotech

Series B in 2023
Hongyun Biotech is a biotech company that promotes therapeutic innovation based on structural pharmacology.

China Immunotech

Series B in 2022
China Immunotech is a small molecule innovative drug R&D company developing immune cell therapy technologies and products. Including CAR-T and TCR-T cell therapy with independent intellectual property rights. It was founded in March 2018 by famous immunologists.

Immupeutics Medicine

Seed Round in 2021
Immupeutics Medical Technology Co., Ltd. is a biomedical research technology company dedicated to the development and application of tumor immunotherapy technology. The company mainly involves the research and application of immunotherapy for many different types of tumors.

NeuralGalaxy

Series A in 2021
Neural Galaxy is a brain science company that originated at Harvard Medical School and the Massachusetts Institute of Technology. The mission of Younao Galaxy is to help solve brain diseases and achieve greater intelligence. Focusing on global vision, based on breakthrough brain science research results, using new software and hardware technologies, Younao Galaxy helps humans to deeply understand our brains, understand high-level intelligence, and solve the enormous challenges facing human society.

Slichem

Series A in 2021
Slichem develops liquid crystal materials and fine chemicals. They manufacture display materials. Their products include liquid crystal materials for display and OLED materials.

Venmedtech

Series B in 2021
Venmedtech produces testing, inspection, and processing equipment. They engaged in the research and development of production and sales of interventional devices related to venous vascular diseases.

Chinagene Tech

Seed Round in 2021
Beijing Zhongyin Technology Co., Ltd. is a professional enterprise engaged in the research and development of clinical genetic diagnosis, prevention and gene therapy for hereditary eye diseases. The company's clinical genetic diagnosis platform for hereditary eye diseases can provide fast, accurate, reliable and professional clinical genetic diagnosis services for hereditary ophthalmology patients.

Insight Lifetech

Series B in 2020
Insight Lifetech is a medical technology company dedicated to the development of innovative solutions that have the potential to transform the precision diagnosis and treatment of cardiovascular diseases. It has created a synergistic platform that seamlessly integrates its R&D, manufacturing, and commercialization capabilities, enhancing collaboration across functions, speeding up product development, achieving cost-efficiency, and promoting innovation. It created the first and only domestic fractional flow reserve (FFR) system in China that was approved by the NMPA.

OptoMedic

Series C in 2020
OptoMedic is specializing in the research and development and production of high-end optical medical devices and systems.

Sensylink

Series B in 2019
Sensylink Microelectronics Co, Ltd., designs, develops, manufactures and markets environmental sensor ICs, including Temperature sensor IC, Humidity sensor IC and Gas sensor IC. Sensylink’s products combine the innovative sensor technology and IC process/design technology together. As a result, Sensylink’s products are highly integrated, high precision, miniature size, low power consumption and low cost. Sensylink’s mission is to be based in China and to provide worldwide customers with the most cost-effective environmental sensor components and services.
Beijing Lidakang Technology is a maker of artificial body joints.

RealAI

Angel Round in 2019
RealAI is an AI tech firm providing services like financial smart risk control & management, and a face recognition system.

Hanyu Medical

Series B in 2018
Hanyu Medical is one of the first domestic companies to develop, produce, and sell transcatheter mitral valve repair devices. At present, the company’s core product is Valve Clamp, a mitral valve interventional device, which is used for minimally invasive interventional treatment of mitral valve regurgitation diseases.

Kanova

Series A in 2018
Kanova is a biopharmaceutical company that focuses on developing therapeutic antibodies and innovative combination therapies in immuno-oncology and autoimmune diseases.

Chinac.com

Series E in 2018
Chinac.com (华云数据) is a Chinese domestic cloud computing infrastructure operator. It is focused on the research, development, and operation of commercial cloud computing infrastructure, targeting the domestic and global clients to provide cloud computing-based IT solutions and outsourcing services. Chinac.com is also known as a SaaS-based provider, PaaS-based provider, traditional software development company, and system integrator. It is also the service provider of thousands of online games, e-commerce, mobile internet, online education, social networking sites, video interaction, and more. Chinac.com has tens of thousands of physical server clusters and 20 data centers in more than 15 cities. Its network covers China Telecom, China Unicom, and BGP Network.

Kiwi Green Technologies

Series A in 2018
Kiwi Green Technologies is a recycling technology developer.

Intengine Technology

Series A in 2018
Tanjing Technology is a storage-first architecture, which provides end-side AI chips and solutions for various IoT terminal devices.

SINOGENE

Series A in 2018
Sinogene uses a solution called somatic cell nuclear transfer for pet cloning. Sinogene believes that the advancement of breeding and genetics will be beneficial to animal genetic research. The company's team includes scientists, doctors, and veterinary specialists.

Cameraking Technology

Angel Round in 2017
Cameraking Technology is the distributor of the Internet of Things and applications to achieve image products. They are capable of designing core devices, integrating the supply chains of various industries, and producing and manufacturing goods. They offer manufacturing services as well as prompt, competent support for imaging technology. Their organization is made up of chip companies, solution providers, the internet of things, AI, and subindustry leaders.

Suzhou Ribo Life Science

Series B in 2017
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.

ZIyan UAV

Series A in 2016
ZIYAN UAV is a research and development company that is introducing small and medium-sized electric unmanned helicopters. Its unmanned helicopters were also used for civilian purposes such as power line inspection, public security, mining, mapping, and other civil applications. It integrated comprehensive solutions such as moving base technology, swarm technology, AI modules, and SAAS software system, as well as the Cloud system, to implement Internet of Things platforms to make data access and intelligent decision-making easier for users.

UWorld

Series A in 2016
UWorld is a mobile merchant platform that provides billing services.

Replays

Angel Round in 2015
Replays is an e-sports comprehensive website mainly provides content such as sports video, industry news, tactical reports, and interviews.

Laviana Pharma

Series A in 2014
Laviana Pharma Co., Ltd. founded in 2005 is a high-tech enterprise. It specializes in providing process and manufacture outsourcing services (CDMO) for the pharmaceutical industry. The main scope of services covers all chemistry-related aspects of process development and transformation for the innovative drug substances and products from laboratory scale to commercialized scale, including process research, process development, process optimization, pilot production and large-scale production of intermediates, API starting materials and API (active pharmaceutical ingredient) for pre-clinical, clinical trial materials and commercialized products. It also provides CMC services for IND and NDA submission of innovative developmental drug. It has three wholly-owned subsidiary, namely, Beijing laviana Pharmatech Co., Ltd., Laviana (Tianjin) Pharmatech Development Co., Ltd., and Laviana Corporation incorporated in United States.

SolarVista Media

Series D in 2013
SolarVista Media provides DCP billboards that run on natural light to change images electronically with no plastic waste when campaigns change.

Palmap

Series B in 2013
Palmap is the largest indoor map data and location based service provider. It devotes to providing professional indoor map, positioning, big data analysis based on position services to commercial complexes, tourist destinations, hospitals, exhibitions, transportation centers, educational places and etc. Palmap has the largest indoor map database in China, which currently accumulated 20,000 sets of indoor maps, 3,500,000 of POI (Point of Interest). The database covers 350 cities around China and includes 79 different types of buildings. The map engine has 2D, 2.5D, 3D forms on demonstration, and the map is in vector format which supports rotating, zooming, rendering, navigating and other functions. In purpose of bringing comprehensive solutions to operators and high quality experience for traffics, Palmap strives to research and develop in modern positioning technology on both WiFi and BLE. With high accuracy map and positioning technology, Palmap positioning engine achieves 3-5 meters precision for WiFi positioning and 1-3 meters for BLE positioning. Palmap provide visual demonstration on analyzing the positioning data based on the WiFi cloud side positioning principles on people. The dimensionality of the positioning data are passenger flow, average duration of stay of passenger, contrast of old and new passengers, frequency on visiting of passenger, trajectory of passenger, and the analysis result will be demonstrated by customer profile and hotspot graph. This system has been applied to commercial complexes, transportation centers and so on. It helps the operators to enhance their operating management so that they can do precision marketing and structural configuration optimizing to improve the service standard. Palmap was founded by Yang Zhang on December 10, 2012 in Shanghai, China.

Baiwan

Series A in 2013
Baiwan is an interactive entertainment platform. They provide mobile terminal users with quality content such as small games, animations, MTV, web games, and online entertainment. They make web games more colorful, ubiquitous, and fun. They offer smart phone software based on android, symbian and apple systems.

Hisign Technology

Series C in 2012
Beijing Hisign Technology Co., Ltd. (Hisign), established in 1998, is a high-growth enterprise group including wholly owned, controlled and shareholding subsidiaries. It is ISO 9001, ISO/IEC20000-1 and ISO/IEC27001 certified. It is a national high-tech enterprise of China. Beijing Hisign Technology Co., Ltd. is widely regarded as the most comprehensive and perfect enterprise in Chinese multi-biometrics industry, with state-of-art techniques of face recognition, fingerprint identification, palm print matching, handwriting and vehicle license plate recognition etc. Its products and businesses cover four fields: multi-biometrics recognition, video image processing and analysis, the comprehensive application of criminal investigation information, as well as financial risk prevention and control with big data analysis. The products are widely used in public security fields such as criminal investigation, security, forensics, border control, and also in civil fields such as finance, social security, education, transportation, large-scale event management, surveillance and internet application.

AISpeech

Series A in 2012
AISpeech is a high-tech start up specialized in computer speech recognition, analysis, tone analysis and dialog management techniques.

Global Gem Exchange

Angel Round in 2011
Global Gem Exchange is a third party jewelry and jade trading platform.

Shenogen Pharma Group

Series A in 2011
Shenogen Pharma Group is a drug discovery and development company.

ChineseAll Digital Publishing

Venture Round in 2010
Chinese Online (中文在线) is a company focused on digital publishing. It provides digital reading products to mobile phones, hand-held terminals, and the internet as well as other media. Chinese Online takes copyright organizations and authors as the genuine digital content source, and collaborates with them to manage the content. It also offers value-added services of digital content such as copyright derivatives and more. As a leading enterprise of digital publishing domestically, Chinese Online has established a complete media publishing model of unique content, variety in media and synchronized publishing.

UNIFLY

Post in 2010
UNIFLY manufacturer of energy saving filters and lubricating oil products for vehicles. Their products include synthetic lubricant, glass cleaner, coolant, porcelain lubricant, and power steering fluid. They also provide technical support, sales, research, and development support.

UNIFLY

Angel Round in 2007
UNIFLY manufacturer of energy saving filters and lubricating oil products for vehicles. Their products include synthetic lubricant, glass cleaner, coolant, porcelain lubricant, and power steering fluid. They also provide technical support, sales, research, and development support.

Achievo

Series B in 2007
Achievo provides specialized IT services and solutions to a global client base and is focused on delivering IT initiatives more efficiently, cost effectively and with less risk, allowing our clients to improve profitability and drive business growth.

Sumavision

Series D in 2006
Beijing Sumavision Co., Ltd. is a Chinese high-tech company that provides digital TV software and systems. Sumavision is the only company that can provide digital TV complete system solutions and one-stop service. Its front-end hardware products took first place in the domestic market share for seven successive years, and also took 50% of the market share in national digital TV translation provinces. The products of Sumavision are used in 43 provinces and regions in China, and over 40 national and provincial broadcast and TV arterial grid or centering systems, as well as over 700 TV city and county stations. Its market share takes the lead among similar Chinese products. In the overseas market, Sumavision's products have been imported to over 70 countries and regions. At present, the volume of trade in Europe and North America takes one third of the whole volume of overseas trade. As of March 2000, Sumavision has a registered capital of 112 million RMB. In 2010, Sumavision successfully got listed on China's Growth Enterprise Market. Currently, Sumavision has a market value of about 7 billion. It is also financed by Beijing Gehua Cable TV Network, Hunan TV & Broadcast Intermediary, and TusPark.

ACCB Biotech

Series A in 2005
Beijing ACCB Biotech Ltd. (雅康博生物) is focused on the research and development of cancer detection methods through the application of molecular biology technologies. Based on the concept of personalized therapy, the company provides detection services that include early-cancer screening, drug selection, effect tracking, prognostic evaluation, transfer and recurrence monitoring, and other testing services. ACCB Biotech’s product series include EnzymAct, Baikangan, Gene 21 of Breast Cancer, automated workstation for nucleic acid extraction, and more. The company now has production, research and development, and service facilities of more than 3,000 square meters, and its cleanliness attains the criteria of 10,000 grades. In June, 2009, EnzymAct® was successfully approved by the State Food and Drug Administration.

Sumavision

Series B in 2001
Beijing Sumavision Co., Ltd. is a Chinese high-tech company that provides digital TV software and systems. Sumavision is the only company that can provide digital TV complete system solutions and one-stop service. Its front-end hardware products took first place in the domestic market share for seven successive years, and also took 50% of the market share in national digital TV translation provinces. The products of Sumavision are used in 43 provinces and regions in China, and over 40 national and provincial broadcast and TV arterial grid or centering systems, as well as over 700 TV city and county stations. Its market share takes the lead among similar Chinese products. In the overseas market, Sumavision's products have been imported to over 70 countries and regions. At present, the volume of trade in Europe and North America takes one third of the whole volume of overseas trade. As of March 2000, Sumavision has a registered capital of 112 million RMB. In 2010, Sumavision successfully got listed on China's Growth Enterprise Market. Currently, Sumavision has a market value of about 7 billion. It is also financed by Beijing Gehua Cable TV Network, Hunan TV & Broadcast Intermediary, and TusPark.

Sumavision

Series A in 2001
Beijing Sumavision Co., Ltd. is a Chinese high-tech company that provides digital TV software and systems. Sumavision is the only company that can provide digital TV complete system solutions and one-stop service. Its front-end hardware products took first place in the domestic market share for seven successive years, and also took 50% of the market share in national digital TV translation provinces. The products of Sumavision are used in 43 provinces and regions in China, and over 40 national and provincial broadcast and TV arterial grid or centering systems, as well as over 700 TV city and county stations. Its market share takes the lead among similar Chinese products. In the overseas market, Sumavision's products have been imported to over 70 countries and regions. At present, the volume of trade in Europe and North America takes one third of the whole volume of overseas trade. As of March 2000, Sumavision has a registered capital of 112 million RMB. In 2010, Sumavision successfully got listed on China's Growth Enterprise Market. Currently, Sumavision has a market value of about 7 billion. It is also financed by Beijing Gehua Cable TV Network, Hunan TV & Broadcast Intermediary, and TusPark.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.